Is Vericel Corp Ord (VCEL) overvalued? · P/E 835, rev $237.2M
Vericel Corp Ord (VCEL) is a biotechnology company listed on US.
This page asks whether Vericel Corp Ord (VCEL) looks expensive on cached numbers — not a short thesis.
Latest reported VCEL revenue for 2024-12-31 was $237.2M. Net income was $10.4M. Revenue was up 20.1% from 2023-12-31 to 2024-12-31. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
VCEL currently screens at market cap $2.10B and trailing P/E 834.8. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next VCEL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the VCEL stock page for the full model, not this heading.
Not investment advice.